Surgical Innovations Group plc (AIM:SUN)
London · Delayed Price · Currency is GBP · Price in GBX 0.4500
0.00 (0.00%)
Feb 13, 2026, 8:00 AM GMT
AIM:SUN Revenue
Surgical Innovations Group had revenue of 6.15M GBP in the half year ending June 30, 2025, with 8.76% growth. This brings the company's revenue in the last twelve months to 11.92M, down -4.98% year-over-year. In the year 2024, Surgical Innovations Group had annual revenue of 11.95M, down -0.57%.
Revenue (ttm)
11.92M
Revenue Growth
-4.98%
P/S Ratio
0.35
Revenue / Employee
140.18K
Employees
85
Market Cap
4.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.95M | -69.00K | -0.57% |
| Dec 31, 2023 | 12.01M | 674.00K | 5.94% |
| Dec 31, 2022 | 11.34M | 2.21M | 24.26% |
| Dec 31, 2021 | 9.13M | 2.80M | 44.19% |
| Dec 31, 2020 | 6.33M | -4.40M | -41.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Cambridge Nutritional Sciences | 8.06M |
| Proteome Sciences | 4.53M |
| Feedback | 885.62K |
| N4 Pharma | 7.07K |
Surgical Innovations Group News
- 3 months ago - Half Year 2025 Surgical Innovations Group PLC Investor Briefing Transcript - GuruFocus
- 1 year ago - AIM Market Roundup: Gelion, Surgical Innovations, Deltex Medical - The Armchair Trader